170843 ⎘
Detection or diagnosis of diseases; Neurological disorders; Dementia; Cognitive disorders Prion diseases
Device for Detecting Misfolded Proteins and Methods of Use Thereof
#2KIT FOR QUIESCENT DETECTING ALPHA-SYNUCLEIN AGGREGATES
#3REACTION VESSEL
#4METHODS AND MATERIALS FOR DETECTING PRION DISEASES
#5METHODS AND MATERIALS FOR DETECTING MISFOLDED POLYPEPTIDES
#6DEVICE FOR DETECTING MISFOLDED PROTEINS AND METHODS OF USE THEREOF
#7MONOCLONAL ANTIBODIES AGAINST PATHOLOGICAL TAU, AND METHODS USING SAME
#8Diagnosing a Disease Associated with Synaptic Degeneration using an Elisa for Determining a Beta-Synuclein Concentration in CSF
#9Chimeric protein in the treatment of amyloidosis
#10Novel Diagnostic Marker for Creutzfeldt-Jakob Disease and Alzheimer's Disease
#11METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#12TEST METHODS FOR DIAGNOSING CHRONIC WASTING DISEASE
#13NEW ANTI TAU SVQIVYKPV EPITOPE SINGLE DOMAIN ANTIBODY
#14DEVICE FOR DETECTING MISFOLDED PROTEINS AND METHODS OF USE THEREOF
#15Anti-Tau antibodies and methods of use
#16ASSAYS TO DETECT NEURODEGENERATION
#17METHODS FOR IDENTIFYING AND QUANTITATING HOST CELL PROTEIN
#18METHOD FOR QUANTIFYING PROTEIN AGGREGATES OF A PROTEIN MISFOLDING DISEASE IN A SAMPLE
#19Shear Force Generating Device for Analysis of Biopsied Mammalian Samples
#20Assays to detect neurodegeneration
#21P-phenylene ethynylene compounds as bioactive and detection agents
#22Device for detecting misfolded proteins and methods of use thereof
#23FKBP52-TAU INTERACTION AS A NOVEL THERAPEUTICAL TARGET FOR TREATING THE NEUROLOGICAL DISORDERS INVOLVING TAU DYSFUNCTION
#24Biomarker for mental disorders including cognitive disorders, and method using said biomarker to detect mental disorders including cognitive disorders
#25Anti-Tau antibodies and methods of use
#26Method for the preselection of drugs for protein misfolding diseases
#27Assays to detect neurodegeneration
#28Anti-alpha synuclein binding molecules
#29Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
#30Chimeric protein in the treatment of amyloidosis
#31Methods for the treatment of neurological disorders
#32DETECTION OF INFECTIOUS PRION PROTEIN BY SEEDED CONVERSION OF RECOMBINANT PRION PROTEIN
#33FKBP52-TAU INTERACTION AS A NOVEL THERAPEUTICAL TARGET FOR TREATING THE NEUROLOGICAL DISORDERS INVOLVING TAU DYSFUNCTION
#34Alpha-Synuclein Antibodies (7A11)
#35METHODS AND COMPOSITIONS TO TREAT AND DETECT MISFOLDED-SOD1 MEDIATED DISEASES
#36Methods and compositions for the treatment of symptoms of prion diseases
#37ANTI-ALPHA-SYNUCLEIN ANTIBODIES AND METHODS OF USE
#38Detection of aggregated proteins associated with neurodegenerative disease using a photooxidation-induced amplification immunoassay
#39Anti-alpha synuclein binding molecules
#40METHODS OF DIAGNOSING ALS
#41Methods and kits for detecting brain injury
#42Process for diagnosis of neurodegenerative diseases
#43METHOD FOR ENRICHING CNS-DERIVED EXOSOMES
#44Prion free nanoparticle compositions and methods of making thereof
#45In vitro detection of prions in blood
#46Device for detecting misfolded proteins and methods of use thereof
#47Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders
#48ASSAY FOR PRIONS
#49CHIMERIC PROTEIN IN THE TREATMENT OF AMYLOIDOSIS
#50Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
#51Vaccine formulations comprising quillaja desacylsaponins and beta amyloid peptides or tau protein to induce a Th2 immune response
#52Computer systems for treating diseases
#53IN VITRO DETECTION OF PRIONS IN BLOOD
#54Anti-α-synuclein antibodies and methods of use
#55FKBP52-Tau interaction as a novel therapeutical target for treating the neurological disorders involving Tau dysfunction
#56Amyloidosis-inhibiting polypeptides and their use
#57Method for diagnosing neurodegenerative diseases
#58Antibodies that bind amyloid oligomers
#59Prion epitopes and methods of use thereof
#60Methods and compositions for the treatment of symptoms of prion diseases
#61BIOMARKER FOR NEURODEGENERATION IN NEUROLOGICAL DISEASE
#62Antibodies and conjugates that target misfolded prion protein
#63MULTIPLEX AVIDITY PROFILING OF PROTEIN AGGREGATES
#64Chronic Traumatic Encephalopathy in Blast-Exposed Individuals
#65STANDARD FOR QUANTIFYING PATHOGENIC AGGREGATES FROM PROTEINS PRODUCED NATURALLY IN THE BODY
#66Protein chips, preparation and use thereof
#67METHODS OF DIAGNOSING TAU-ASSOCIATED NEURODEGENERATIVE DISEASES
#68Prion disease-specific epitopes and methods of use thereof
#69Anti-α synuclein binding molecules
#70Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
#71Methods of diagnosing ALS
#72Prion free nanoparticle compositions and methods of making thereof
#73Methods for analyzing blood to detect diseases associated with abnormal protein aggregation
#74Prion protein ligands and methods of use
#75Discordant helix stabilization for prevention of amyloid formation
#76High-affinity monoclonal anti-prion antibodies
#77Aptamers for prion diagnostics and aptamer binding detection system
#78Computer systems for treating diseases
#79Assay for prions
#80Methods and compositions for the treatment of symptoms of prion diseases
#81Computer systems for treating diseases
#82Method for non-covalent immobilization of infectious prion protein
#83VCJD CONFIRMATORY SCREENING ASSAY
#84DETECTION OF INFECTIOUS PRION PROTEIN BY SEEDED CONVERSION OF RECOMBINANT PRION PROTEIN
#85FKBP52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction
#86LIPID COFACTORS FOR FACILITATING PROPOGATION OF PRPsc
#87Nanobeads covered with plasminogen as a direct support for cyclic amplification of the prion protein PrP
#88Methods of treating diseases
#89BIOMARKER FOR NEURODEGENERATION IN NEUROLOGICAL DISEASE
#90Biomarker for psychiatric diseases including cognitive impairment and methods for detecting psychiatric diseases including cognitive impairment using the biomarkers
#91Antibodies that bind amyloid oligomers
#92Antibodies And Epitopes Specific To Misfolded Prion Protein
#93Methods of diagnosing ALS
#94Method and a Kit To Detect Malignant Tumors and Provide a Prognosis
#95IRAK KINASE FAMILY AS NOVEL TARGET AND BIOMARKER FOR ALZHEIMER
#96Methods for the Detection and Treatment of Aberrant Prion Disease
#97Binding of aggregated forms of proteins
#98ENRICHMENT AND PURIFICATION OF INFECTIOUS PRION PROTEINS
#99Use of psychrophilic anaerobic digestion in sequencing batch reactor for degradation of prions
#100Methods for estimating prion concentration in fluids and tissue by quantitative PMCA
#101Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
#102High throughput assays for transmissible spongiform encephalopathies (TSE)
#103NEW DRUG FOR INHIBITING AGGREGATION OF PROTEINS INVOLVED IN DISEASES LINKED TO PROTEIN AGGREGATION AND/OR NEURODEGENERATIVE DISEASES
#104METHOD FOR DETECTING A PRION INFECTION
#105SCREENING METHOD FOR POLYMORPHIC MARKERS IN HTRA1 GENE IN NEURODEGENERATIVE DISORDERS
#106MONOCLONAL ANTIBODIES SPECIFIC FOR PATHOLOGICAL AMYLOID AGGREGATES COMMON TO AMYLOIDS FORMED FROM PROTEINS OF DIFFERING SEQUENCE
#107STABLE CLONE CELL EXPRESSING A PRION
#108METHODS AND KITS FOR DIAGNOSING NEURODEGENERATIVE DISEASE
#109METHOD OF DETECTION AND/OR TITRATION IN VITRO OF AN UNCONVENTIONAL TRANSMISSIBLE AGENT
#110Antibodies that bind ALS specific epitopes and methods of making
#111METHOD FOR EFFICIENTLY AMPLIFYING ABNORMAL PRION PROTEIN DERIVED FROM BSE
#112Detection of pathogenic abeta using an epitope protection assay
#113Detection of analytes present in exosomes
#114Method for detecting misfolded proteins and prions
#115Method for detecting or determining abnormal prion protein associated with transmissible spongiform encephalopathy in blood-derived specimen or body fluid-derived specimen
#116NOVEL ANTIBODIES AGAINST PRION PROTEIN AND USES THEREOF
#117BINDING OF PATHOLOGICAL FORMS OF PROTEINS USING CONJUGATED POLYELECTROLYTES
#118BINDING OF PATHOLOGICAL FORMS OF PROTEINS USING CONJUGATED POLYELECTROLYTES
#119PRION FREE NANOPARTICLE COMPOSITIONS AND METHODS OF MAKING THEREOF
#120PRION ELISA
#121Misfolded protein sensor method
#122RAPID ANTEMORTEM DETECTION OF INFECTIOUS AGENTS
#123Abnormal prion protein binder, and method for detection of abnormal prion protein
#124PRION ASSAY
#125Binding of pathological forms of prion proteins
#126Compositions and Methods for Detecting and Quantifying Toxic Substances in Disease States
#127DISCORDANT HELIX STABILIZATION FOR PREVENTION OF AMYLOID FORMATION
#128Methods and compositions for the treatment and diagnosis of cancer
#129Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amyloid beta
#130METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF PRION DISEASES
#131Detection and/or Characterisation of Oligomers
#132High throughput assays for transmissible spongiform encephalopathies (TSE)
#133METHODS FOR THE DIAGNOSIS OF PROLIFERATIVE AND/OR CONFORMATIONAL DISEASES
#134Assay for transmissible spongiform encephalopathies
#135Method for detecting PrP using at least one positive charge and/or at least one glycosidic bond and a ligand other than a protein ligand
#136Prion epitopes and methods of use thereof
#137Method of Quickly Detecting Antigen Using Fluorescence Correlation Spectroscopy or Fluorescence Cross-Correlation Spectroscopy
#138Method to measure and characterize microvesicles in the human body fluids
#139METHOD FOR RAPID SCREENING OF MAD COW DISEASE AND OTHER TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
#140METHODS FOR DETECTION OF PATHOGENIC PRION PROTEINS ASSOCIATED WITH PRION DISEASES, USING CONJUGATED POLYELECTROLYTES
#141Diagnostic assay for spongiform encephalopathies
#142Electrical Conductors and Devices from Prion-Like Proteins
#143Isolation and Detection of Pathogenic Prions
#144TEST FOR THE DETECTION OF PATHOLOGICAL PRIONS
#145Reagents and Methods for the Detection of Transmissible Spongiform Encephalopathy
#146Peptides for discrimination of prions
#147Elisa assays using prion-specific peptide reagents
#148Method useful for detecting encephalopathies
#149Antibodies for discrimination of prions
#150ALS-specific peptide composition
#151INFECTIVITY ASSAY
#152Identification of Prion Proteins in Milk
#153Prion-specific peptide reagents
#154Detection of infectious prion protein by seeded conversion of recombinant prion protein
#155Method for the Selective Detection of Pathological Protein Depositions
#156Cjd Prion Testing
#157Soluble Hybrid Prion Proteins And Their Use In The Diagnosis, Prevention And Treatment Of Transmissible Spongiform Encephalopathies
#158Methods and compositions for monitoring progression of huntington's disease
#159Substituted triazines as prion protein ligands and their use to detect or remove prions
#160Prion protein ligands and methods of use
#161Compositions and methods for enhancing the identification of prior protein PrP
#162Methods of detection using immuno-Q-Amp technology
#163Protein Immobilization Method and Quantification Method
#164Method for the Detection of Disease-Related Prion
#165Diagnosis of neurodegenerative diseases
#166Degradation and detection of TSE infectivity
#167Method for detecting PrP using at least one positive charge and/or at least one glycosidic bond and a ligand other than a protein ligand
#168Detection of conformationally altered proteins and prions
#169Prion test
#170Methods for rapid screening of mad cow disease and other transmissible spongiform encephalopathies
#171Methods and Compositions for the Detection of Protein Folding Disorders
#172Immunoassay for Prion Disease
#173Method and Detection of the Presence of Prions Protein
#174Diagnostics And Therapeutics For Transmissible Spongiform Encephalopathy And Methods For The Manufacture Of Non-Infective Blood Products And Tissued Derived Products
#175Detection of Protein Aggregates by Homologous Elisa
#176Anti-Lipid Rafts Antibodies
#177COMPOSITIONS AND METHODS FOR DETECTING AND QUANTIFYING TOXIC SUBSTANCES IN DISEASE STATES
#178Identification of leucocytes bearing diagnostic markers for transmissible spongiform encephalopathies
#179Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
#180Antibodies for specifically detecting pathogenic prions of human origin, and detection methods carried out using these antibodies
#181Diagnosis of transmissible spongiform encephalopathy
#182PRION PROTEIN DETECTION
#183METHODS OF IN VITRO PROPAGATION AND DETECTION OF INFECTIOUS PRION
#184Method of quickly detecting and/or assaying antigen by fluorescence correlation spectrometry
#185Process for detecting PrP using a macrocyclic adjuvant ligand
#186Methods for isolating proteons from plasma samples
#187Anti-candida agents for the treatment of prion diseases
#188Methods and kits for detection of prion diseases
#189antibodies binding to a C-terminal fragment of apoliopoprotein E
#190Peptides for discrimination of prions
#191Methods and kits for the detection of prion diseases
#192Epitope protection assay and method for detecting protein conformations
#193Methods and apparatus for reference lab diagnostics
#194Misfolded protein sensor method
#195Misfolded protein sensor method in body fluids
#196Ultrasensitive detection of prions by automated protein misfolding cyclic amplification
#197ALS-specific peptide composition
#198ANTIBODIES SPECIFIC FOR UNGULATE PrP
#199Methods for detecting and inactivating a prion
#200Rapid prion-detection assay
#201Methods of detection using immuno-Q-Amp technology
#202Method capable of being automated for detection of prpres and uses thereof
#203PrP-selective peptides
#204Method of preparing cow brain homogenate
#205Detection of protease-resistant prion protein following a spontaneous transformation reaction
#206Detection of protease-resistant prion protein after asymmetric spontaneous interaction
#207“Prionins”, highly specific markers for noninvasive presymptomatic detection of TSE diseases, and targets for therapeutic reagents to prevent and control TSE diseases in animals and humans
#208Compositions and methods for enhancing the identification of prion protein PrP
#209Compositions and methods for enhancing the identification of prion protein PRP
#210Piezoelectric bio-chip for detecting pathogen of mad cow disease and thereon preparation
#211High throughput prion assays
#212Methods to differentiate protein conformers
#213Method for enriching and tracking pathologic modified prions-proteins(prpsc)
#214Method for diagnosing a transmissible spongiform subacute encephalopathy caused by an unconventional transmissible agent strain in a biological sample
#215Immobilized probes and methods of detecting conformationally altered prion proteins
#216Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins
#217Diagnostic method for a transmissible spongiform encephalopathy or prion disease
#218Compositions and methods used for identifying factors required for the agglomeration of proteins
#219Prion-specific peptide reagents
#220Detection and quantification of prion isoforms in neurodegenerative diseases using mass spectrometry
#221Rapid prion-detection assay
#222Methods of detection employing immuno-Q-Amp technology
#223Process for detecting PrP using a macrocyclic adjuvant ligand
#224Process for detecting PrPusing an antibiotic from the family of aminoglycosides
#225Methods for rapid screening of mad cow disease and other transmissible spongiform encephalopathies
#226Method of preparing cow brain homogenate
#227High-sensitivity chemiluminescent ELISA prion detection method
#228Electrical conductors and devices from prion-like proteins
#229Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
#230Safe method for isolation of prion protein and diagnosis of transmissible spongiform encephalopathies
#231Diagnosis of demyelinating or spongiform disease
#232Transmissible spongiform encephalopathy test reagents and methods
#233Device and methods for concentrating prion protein isoforms
#234Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPSc
#235Binding of pathological forms of prion proteins
#236Method
#237Prion protein standard and method of making same
#238Diagnosis of spongiform disease
#239Methods of detection employing immuno-Q-Amp technology
#240Antibodies specific for native PrP
#241Rapid prion-detection device, system and test kit
#242Amyloid beta-peptide and methods of use
#243Method for the detection of proteins of animal origin in complex mixtures
#244Prion-specific peptide reagents
#245Detection of prion disease
#246Rapid method of determining clearance of prion protein
#247Urine test for the diagnosis of prion diseases
#248Detection and quantification of prion isoforms in neurodegenerative diseases using mass spectrometry
#249Early diagnosis of conformational diseases
#250Discordant helix stabilization for prevention of amyloid formation
#251Models of prion disease
#252Method for the detection of prion diseases
#253Method for identifying ligands specific for structural isoforms of proteins
#254Detection of conformationally altered proteins and prions
#255Use of 14-3-3 proteins and a method for determining the same in the fluids or tissues of organisms
#256In vitro detection of prions